Market Overview:
The global central venous access devices market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic diseases, rising geriatric population, and technological advancements in central venous access devices. Based on type, the global central venous access devices market is segmented into peripheral, PIV catheters, midline catheters, and others. The PIV catheter segment is expected to grow at the highest CAGR during the forecast period from 2018 to 2030. This growth can be attributed to its growing use for drug administration and other applications such as blood transfusion and diagnostics & testing. Based on application, the global central venous access devices market is segmented into drug administration, fluid and nutrition administration, blood transfusion, and diagnostics & testing.
Product Definition:
Central Venous Access Devices (CVADs) are tubes placed into a vein in the arm, neck, or chest to allow easy access to the bloodstream for drawing blood, giving fluids and other treatments, and taking measurements.
Peripheral:
Peripheral devices are used to access the central venous system. Central venous access is a technique of fluid therapy in which, the blood is drawn from one or more central veins through a peripheral device such as catheters, cannulae and tunnels. Peripheral devices are also known as peripheral intravenous equipment or IVA (intravenous access).
PIV Catheters:
PIV catheters are used to access the central venous system. Central venous access devices market is expected to witness lucrative growth over the forecast period owing to increasing prevalence of chronic diseases such as cancer, high blood pressure, and diabetes which require long term treatment. Increasing demand for home healthcare services and rising geriatric population base across the globe is also anticipated to drive this market in future.
Application Insights:
Drug administration held the largest share of venous access devices application in 2017. This is due to the increasing prevalence of chronic diseases such as cancer, heart diseases and respiratory disorders that require long-term medication. Thus, central venous catheters are used for drug administration in patients with conditions such as diabetes and kidney failure.
The diagnostics & testing segment is expected to grow at a lucrative rate over the forecast period owing to an increase in demand for point-of-care testing across various applications including oncology, infectious disease management and neurology. The availability of advanced technologies such as radiology-based vascular imaging has led to an increased number of diagnostic procedures performed using interventional radiology techniques such as catheter angiography or vascular ultrasound which requires central venous access devices for image guidance during procedures.
Regional Analysis:
North America dominated the global central venous access devices market in 2017. This can be attributed to favorable reimbursement policies, increasing incidence of chronic diseases, and rising awareness about CVAAs. Moreover, presence of key players such as Medtronic; Unilife Corporation; B. Braun Melsungen AG; Terumo Medical Corporation is also contributing towards the growth of this regional market.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to factors such as improving healthcare infrastructure and growing target population base with high unmet needs for CIVA treatment options in emerging countries like China & India due to lack of suitable alternatives for peripheral IV catheters or midline catheters that are used widely in hospitals & clinics along with PIVCs that provide better control over fluid balance during surgeries or diagnostic procedures compared to central line based techniques thus making it an attractive opportunity for global players operating within this space.
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyle and dietary habits of people across the world. Central venous access devices are increasingly becoming an integral part of the treatment regimen for patients with chronic diseases, as they help in delivering medications and other treatments directly to the blood vessels.
- Technological advancements: The central venous access device market is witnessing rapid technological advancements, with manufacturers introducing new products that are easier to use and provide better patient outcomes. For instance, in 2016, Cook Medical introduced a novel central venous access device called Celect Venous Catheter that uses electromagnetic navigation technology to help physicians place catheters more accurately in difficult-to-reach veins. Such technological advances are likely to boost demand for central venous access devices in the coming years.
- Growing geriatric population: The global geriatric population is growing rapidly due to improvements in healthcare infrastructure and increased life expectancy across the world. This has led to an increase in demand for medical procedures and treatments among elderly patients, many of whom require regular administration of medications or other treatments through a central vein accessed via a central venous access device). Thus, rising geriatric population is one of key growth drivers for this market segment .
Scope Of The Report
Report Attributes
Report Details
Report Title
Central Venous Access Devices Market Research Report
By Type
Peripheral, PIV Catheters, Midline Catheters, Others
By Application
Drug Administration, Fluid and Nutrition Administration, Blood Transfusion, Diagnostics & Testing
By Companies
BD, Teleflex, B.Braun Medical, Merit Medical Systems, AngioDynamics, Argon Medical Devices, Vygon, Baihe Medical, Cook Medical, SCW MEDICATH, Lepu Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Central Venous Access Devices Market Report Segments:
The global Central Venous Access Devices market is segmented on the basis of:
Types
Peripheral, PIV Catheters, Midline Catheters, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Administration, Fluid and Nutrition Administration, Blood Transfusion, Diagnostics & Testing
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD
- Teleflex
- B.Braun Medical
- Merit Medical Systems
- AngioDynamics
- Argon Medical Devices
- Vygon
- Baihe Medical
- Cook Medical
- SCW MEDICATH
- Lepu Medical
Highlights of The Central Venous Access Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Peripheral
- PIV Catheters
- Midline Catheters
- Others
- By Application:
- Drug Administration
- Fluid and Nutrition Administration
- Blood Transfusion
- Diagnostics & Testing
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Central Venous Access Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A central venous access device (CVAD) is a medical device that is inserted into the large veins in your arm to allow doctors to give you intravenous (IV) treatments.
Some of the major companies in the central venous access devices market are BD, Teleflex, B.Braun Medical, Merit Medical Systems, AngioDynamics, Argon Medical Devices, Vygon, Baihe Medical, Cook Medical, SCW MEDICATH, Lepu Medical.
The central venous access devices market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Central Venous Access Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Central Venous Access Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Central Venous Access Devices Market - Supply Chain
4.5. Global Central Venous Access Devices Market Forecast
4.5.1. Central Venous Access Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Central Venous Access Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Central Venous Access Devices Market Absolute $ Opportunity
5. Global Central Venous Access Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Central Venous Access Devices Market Size and Volume Forecast by Type
5.3.1. Peripheral
5.3.2. PIV Catheters
5.3.3. Midline Catheters
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Central Venous Access Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Central Venous Access Devices Market Size and Volume Forecast by Application
6.3.1. Drug Administration
6.3.2. Fluid and Nutrition Administration
6.3.3. Blood Transfusion
6.3.4. Diagnostics & Testing
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Central Venous Access Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Central Venous Access Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Central Venous Access Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Central Venous Access Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Central Venous Access Devices Demand Share Forecast, 2019-2026
9. North America Central Venous Access Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Central Venous Access Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Central Venous Access Devices Market Size and Volume Forecast by Application
9.4.1. Drug Administration
9.4.2. Fluid and Nutrition Administration
9.4.3. Blood Transfusion
9.4.4. Diagnostics & Testing
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Central Venous Access Devices Market Size and Volume Forecast by Type
9.7.1. Peripheral
9.7.2. PIV Catheters
9.7.3. Midline Catheters
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Central Venous Access Devices Demand Share Forecast, 2019-2026
10. Latin America Central Venous Access Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Central Venous Access Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Central Venous Access Devices Market Size and Volume Forecast by Application
10.4.1. Drug Administration
10.4.2. Fluid and Nutrition Administration
10.4.3. Blood Transfusion
10.4.4. Diagnostics & Testing
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Central Venous Access Devices Market Size and Volume Forecast by Type
10.7.1. Peripheral
10.7.2. PIV Catheters
10.7.3. Midline Catheters
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Central Venous Access Devices Demand Share Forecast, 2019-2026
11. Europe Central Venous Access Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Central Venous Access Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Central Venous Access Devices Market Size and Volume Forecast by Application
11.4.1. Drug Administration
11.4.2. Fluid and Nutrition Administration
11.4.3. Blood Transfusion
11.4.4. Diagnostics & Testing
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Central Venous Access Devices Market Size and Volume Forecast by Type
11.7.1. Peripheral
11.7.2. PIV Catheters
11.7.3. Midline Catheters
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Central Venous Access Devices Demand Share, 2019-2026
12. Asia Pacific Central Venous Access Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Central Venous Access Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Central Venous Access Devices Market Size and Volume Forecast by Application
12.4.1. Drug Administration
12.4.2. Fluid and Nutrition Administration
12.4.3. Blood Transfusion
12.4.4. Diagnostics & Testing
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Central Venous Access Devices Market Size and Volume Forecast by Type
12.7.1. Peripheral
12.7.2. PIV Catheters
12.7.3. Midline Catheters
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Central Venous Access Devices Demand Share, 2019-2026
13. Middle East & Africa Central Venous Access Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Central Venous Access Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Central Venous Access Devices Market Size and Volume Forecast by Application
13.4.1. Drug Administration
13.4.2. Fluid and Nutrition Administration
13.4.3. Blood Transfusion
13.4.4. Diagnostics & Testing
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Central Venous Access Devices Market Size and Volume Forecast by Type
13.7.1. Peripheral
13.7.2. PIV Catheters
13.7.3. Midline Catheters
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Central Venous Access Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Central Venous Access Devices Market: Market Share Analysis
14.2. Central Venous Access Devices Distributors and Customers
14.3. Central Venous Access Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BD
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Teleflex
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. B.Braun Medical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Merit Medical Systems
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. AngioDynamics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Argon Medical Devices
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Vygon
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Baihe Medical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Cook Medical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. SCW MEDICATH
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Lepu Medical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
